首页 > 最新文献

Journal of Tongji Medical University = Tong ji yi ke da xue xue bao最新文献

英文 中文
Expression of multidrug-associated protein, P-glycoprotein, P53 and Bcl-2 proteins in bladder cancer and clinical implication. 膀胱癌中多药相关蛋白、P-糖蛋白、P53 和 Bcl-2 蛋白的表达及其临床意义。
Pub Date : 2001-01-01 DOI: 10.1007/BF02888038
Z Chen, Y Zhang, X Zhang, G Du, W Yang, Z Hu, J Li, Y Zhang

The expression of multidrug resistant proteins in bladder cancer and clinical implication was studied. Expression of multidrug-associated protein (MRP), P-glycoprotein (P-gp), P53 and Bcl-2 proteins were detected by using immunohistochemical method in 40 specimens of bladder transitional cell carcinoma. The results showed that the positive rate of MRP, P-gp, P53 and Bcl-2 was 52.5%, 57.5%, 47.5% and 62.5% respectively. The positive rate of MRP, P-gp, P53 and Bcl-2 in the grade I, II and III of tumors was 46.3%, 38.5%, 38.5%, 23.1%; 52.9%, 39.8%, 47.1%, 76.4%; 60.0%, 80.0%, 60.0%, 90.0% respectively. The positive rate of MRP, P-gp, P53 and Bcl-2 in 24 primary tumor specimens was 37.5%, 41.7%, 33.3%, 45.8% and that in 16 cases in recurrent specimens receiving chemotherapy 75.0%, 81.3%, 68.8%, 87.5% respectively. It was suggested the positive rate of MRP, P-gp, P53 and Bcl-2 was increased with the advance of tumor grade. The positive rate of four proteins in all recurrent cases was significantly increased (P < 0.05). The expression of MRP, P-gp, P53 and Bcl-2 proteins might be the important factors for chemotherapy failure.

研究了膀胱癌中多药耐药蛋白的表达及其临床意义。采用免疫组化方法检测了40例膀胱过渡性细胞癌标本中多药相关蛋白(MRP)、P-糖蛋白(P-gp)、P53和Bcl-2蛋白的表达。结果显示,MRP、P-gp、P53 和 Bcl-2 的阳性率分别为 52.5%、57.5%、47.5% 和 62.5%。I、II和III级肿瘤中MRP、P-gp、P53和Bcl-2的阳性率分别为46.3%、38.5%、38.5%、23.1%;52.9%、39.8%、47.1%、76.4%;60.0%、80.0%、60.0%、90.0%。24例原发性肿瘤标本中MRP、P-gp、P53和Bcl-2的阳性率分别为37.5%、41.7%、33.3%和45.8%,16例接受化疗的复发性肿瘤标本中MRP、P-gp、P53和Bcl-2的阳性率分别为75.0%、81.3%、68.8%和87.5%。研究表明,随着肿瘤分级的升高,MRP、P-gp、P53 和 Bcl-2 的阳性率也随之升高。在所有复发病例中,四种蛋白的阳性率均显著升高(P < 0.05)。MRP、P-gp、P53和Bcl-2蛋白的表达可能是导致化疗失败的重要因素。
{"title":"Expression of multidrug-associated protein, P-glycoprotein, P53 and Bcl-2 proteins in bladder cancer and clinical implication.","authors":"Z Chen, Y Zhang, X Zhang, G Du, W Yang, Z Hu, J Li, Y Zhang","doi":"10.1007/BF02888038","DOIUrl":"10.1007/BF02888038","url":null,"abstract":"<p><p>The expression of multidrug resistant proteins in bladder cancer and clinical implication was studied. Expression of multidrug-associated protein (MRP), P-glycoprotein (P-gp), P53 and Bcl-2 proteins were detected by using immunohistochemical method in 40 specimens of bladder transitional cell carcinoma. The results showed that the positive rate of MRP, P-gp, P53 and Bcl-2 was 52.5%, 57.5%, 47.5% and 62.5% respectively. The positive rate of MRP, P-gp, P53 and Bcl-2 in the grade I, II and III of tumors was 46.3%, 38.5%, 38.5%, 23.1%; 52.9%, 39.8%, 47.1%, 76.4%; 60.0%, 80.0%, 60.0%, 90.0% respectively. The positive rate of MRP, P-gp, P53 and Bcl-2 in 24 primary tumor specimens was 37.5%, 41.7%, 33.3%, 45.8% and that in 16 cases in recurrent specimens receiving chemotherapy 75.0%, 81.3%, 68.8%, 87.5% respectively. It was suggested the positive rate of MRP, P-gp, P53 and Bcl-2 was increased with the advance of tumor grade. The positive rate of four proteins in all recurrent cases was significantly increased (P < 0.05). The expression of MRP, P-gp, P53 and Bcl-2 proteins might be the important factors for chemotherapy failure.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 1","pages":"56-8"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52207878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dynamic renal scintigraphy in diagnosis of upper urinary tract obstruction in transplanted kidney. 动态肾脏闪烁扫描在诊断移植肾上尿路梗阻中的应用
Pub Date : 2001-01-01 DOI: 10.1007/BF02888084
Z Xianyu, H Wu, J Zhou, P Zhou, M Zhao

Nuclide renal dynamic imaging was performed on 88 (110 times) transplanted kidney. Two kinds of renal scintigraphic characteristics were identified in recipients with supravesical obstruction of the graft. First, the regular type was characterized by radioactivity defect area in kidney parenchyma during early uptake period followed by ureteropelvic retention. Second, the tubular type was typified by cortical retention and attenuation in collecting system during the whole test period with a special sign of "hollow kidney". Non-obstructive dilated calyces showed similar signs as the regular type. Acute rejection reaction and tubule necrosis demonstrated obstructive time-activity curves. However, the radioactivity retention appeared in cortex. It was suggested that dilated calyces and obstructive renogram might not be reliable evidence for upper urinary tract obstruction. The signs of radioactivity attenuation in kidney parenchyma during early uptake period followed by ureteropelvic retention may be more valuable for the evaluation. As for tubular obstruction, specified "hollow kidney" was the characteristic sign which is helpful for the diagnosis.

对 88 个(110 次)移植肾进行了核素肾动态成像。结果发现,移植肾上静脉阻塞的受者有两种肾脏闪烁成像特征。首先,规则型的特点是在摄取早期肾实质内有放射性缺损区,随后出现输尿管肾盂潴留。其次,肾小管型的典型特征是在整个测试期间肾皮质潴留和集合系统衰减,并伴有 "空心肾 "的特殊体征。非梗阻性扩张肾小管的表现与普通型相似。急性排斥反应和肾小管坏死表现为阻塞性时间-活动曲线。然而,放射性保留出现在皮质中。有人认为,肾盏扩张和梗阻性肾图可能不是上尿路梗阻的可靠证据。肾实质在摄取早期放射性衰减,随后出现输尿管肾盂潴留的迹象可能更有评估价值。至于肾小管梗阻,明确的 "空心肾 "是有助于诊断的特征性体征。
{"title":"Dynamic renal scintigraphy in diagnosis of upper urinary tract obstruction in transplanted kidney.","authors":"Z Xianyu, H Wu, J Zhou, P Zhou, M Zhao","doi":"10.1007/BF02888084","DOIUrl":"10.1007/BF02888084","url":null,"abstract":"<p><p>Nuclide renal dynamic imaging was performed on 88 (110 times) transplanted kidney. Two kinds of renal scintigraphic characteristics were identified in recipients with supravesical obstruction of the graft. First, the regular type was characterized by radioactivity defect area in kidney parenchyma during early uptake period followed by ureteropelvic retention. Second, the tubular type was typified by cortical retention and attenuation in collecting system during the whole test period with a special sign of \"hollow kidney\". Non-obstructive dilated calyces showed similar signs as the regular type. Acute rejection reaction and tubule necrosis demonstrated obstructive time-activity curves. However, the radioactivity retention appeared in cortex. It was suggested that dilated calyces and obstructive renogram might not be reliable evidence for upper urinary tract obstruction. The signs of radioactivity attenuation in kidney parenchyma during early uptake period followed by ureteropelvic retention may be more valuable for the evaluation. As for tubular obstruction, specified \"hollow kidney\" was the characteristic sign which is helpful for the diagnosis.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 2","pages":"156-8"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10037603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization. 肝细胞癌经导管动脉化疗栓塞后微血管密度变化的研究。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886568
J Yi, X Liao, Z Yang, X Li

To study the changes in intratumoral microvessel density (MVD) in hepatocellular carcinoma (HCC) following transcatheter arterial chemoembolization (TACE), MVD in 42 HCC specimens histologically verified was studied by using immunohistochemical method. Of all the specimens, 20 were obtained from the patients treated with surgical resection alone, 22 from those with second stage surgical resection after TACE. The results showed that the MVD in HCC tissues was 53.4 +/- 21.9 in the TACE group and 27.6 +/- 9.2 in the single operating group, respectively, with the difference being significant between them (P < 0.001). It was suggested that TACE might contribute to angiogenesis of HCC, possibly due to anoxic stress and ischemia-reperfusion injury.

为了研究肝细胞癌(HCC)经导管动脉化疗栓塞(TACE)后瘤内微血管密度(MVD)的变化,采用免疫组织化学方法研究了42例经组织学证实的HCC标本的MVD。在所有标本中,20例来自单纯手术切除的患者,22例来自TACE后二期手术切除的患者。结果显示,TACE组HCC组织MVD为53.4 +/- 21.9,单手术组MVD为27.6 +/- 9.2,差异有统计学意义(P < 0.001)。提示TACE可能通过缺氧应激和缺血再灌注损伤促进肝细胞癌血管生成。
{"title":"Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.","authors":"J Yi,&nbsp;X Liao,&nbsp;Z Yang,&nbsp;X Li","doi":"10.1007/BF02886568","DOIUrl":"https://doi.org/10.1007/BF02886568","url":null,"abstract":"<p><p>To study the changes in intratumoral microvessel density (MVD) in hepatocellular carcinoma (HCC) following transcatheter arterial chemoembolization (TACE), MVD in 42 HCC specimens histologically verified was studied by using immunohistochemical method. Of all the specimens, 20 were obtained from the patients treated with surgical resection alone, 22 from those with second stage surgical resection after TACE. The results showed that the MVD in HCC tissues was 53.4 +/- 21.9 in the TACE group and 27.6 +/- 9.2 in the single operating group, respectively, with the difference being significant between them (P < 0.001). It was suggested that TACE might contribute to angiogenesis of HCC, possibly due to anoxic stress and ischemia-reperfusion injury.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 4","pages":"321-2, 331"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02886568","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22205962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Pulmonary sequestration: three dimensional dynamic contrast-enhanced MR angiography and MRI. 肺部嵌塞:三维动态对比增强磁共振血管造影和磁共振成像。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886576
H Xu, D Jiang, X Kong, Y Xiong, D Liu, X Liu, X Deng

In order to evaluate the diagnostic value of three-dimensional contrast-enhanced MR angiography and MRI for pulmonary sequestration, 5 patients with pulmonary sequestration underwent 3D fast imaging by steady state precession (FISP) with a contrast medium and breath holding following chest radiography, CT and MR scans. The reconstructed MR angiography was performed using maximum intensity projection (MIP) and multiplanar reconstruction (MPR) techniques. It was found that the chest radiography showed pulmonary sequestration as a persistent area of opacity in the posterior basal segment of the left lower lobe, which was close to mediastinum in 2 cases and close to diaphragma in 3 cases. CT revealed a soft issue mass beyond descending aorta and lobar emphysema around the pulmonary sequestration. And the supplying vessel was documented in 2 cases on enhanced CT. MRI demonstrated a hyperintensity mass with respect to normal lung parenchyma on T1WI and T2WI, and the origin of the supplying vessel in 3 cases. The reconstructed CE MRA using MIP or MRP techniques clearly showed the supplying vessel and its course, branches as well as draining vessels. It was concluded that 3D CE MRA of demonstrating the supplying and draining vessels to pulmonary sequestration, together with plain MRI, can provide a diagnosis and aid in surgical planning without the need for DSA.

为了评估三维造影剂增强磁共振血管造影和磁共振成像对肺动脉栓塞的诊断价值,5 名肺动脉栓塞患者在接受胸片、CT 和磁共振扫描后,使用造影剂和屏气进行了三维快速稳态前移成像(FISP)。利用最大强度投影(MIP)和多平面重建(MPR)技术对磁共振血管造影进行了重建。结果发现,胸片显示左下叶后基底段有持续性肺不张,其中 2 例接近纵隔,3 例接近膈肌。CT 显示降主动脉外有一软组织肿块,肺栓塞周围有肺叶气肿。2 例病例的增强 CT 显示了供血血管。核磁共振成像在 T1WI 和 T2WI 上显示出相对于正常肺实质的高密度肿块,并在 3 个病例中显示出供血血管的起源。使用 MIP 或 MRP 技术重建的 CE MRA 可清晰显示供血血管及其走向、分支和引流血管。结论是,三维 CE MRA 显示肺动脉栓塞的供血血管和引流血管,再加上普通 MRI,可以提供诊断并帮助制定手术计划,而无需进行 DSA。
{"title":"Pulmonary sequestration: three dimensional dynamic contrast-enhanced MR angiography and MRI.","authors":"H Xu, D Jiang, X Kong, Y Xiong, D Liu, X Liu, X Deng","doi":"10.1007/BF02886576","DOIUrl":"10.1007/BF02886576","url":null,"abstract":"<p><p>In order to evaluate the diagnostic value of three-dimensional contrast-enhanced MR angiography and MRI for pulmonary sequestration, 5 patients with pulmonary sequestration underwent 3D fast imaging by steady state precession (FISP) with a contrast medium and breath holding following chest radiography, CT and MR scans. The reconstructed MR angiography was performed using maximum intensity projection (MIP) and multiplanar reconstruction (MPR) techniques. It was found that the chest radiography showed pulmonary sequestration as a persistent area of opacity in the posterior basal segment of the left lower lobe, which was close to mediastinum in 2 cases and close to diaphragma in 3 cases. CT revealed a soft issue mass beyond descending aorta and lobar emphysema around the pulmonary sequestration. And the supplying vessel was documented in 2 cases on enhanced CT. MRI demonstrated a hyperintensity mass with respect to normal lung parenchyma on T1WI and T2WI, and the origin of the supplying vessel in 3 cases. The reconstructed CE MRA using MIP or MRP techniques clearly showed the supplying vessel and its course, branches as well as draining vessels. It was concluded that 3D CE MRA of demonstrating the supplying and draining vessels to pulmonary sequestration, together with plain MRI, can provide a diagnosis and aid in surgical planning without the need for DSA.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 4","pages":"345-8"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22206414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cloning and identification of a novel variant of human vascular endothelial growth factor. 人血管内皮生长因子新型变体的克隆与鉴定。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886426
J Guo, S Qu

A novel variant of human vascular endothelial growth factor (h'VEGF165) cDNA was amplified by nested PCR method from the HL601 cells and was cloned into a eukaryotic expressing vector pcDNA3 to construct a recombinant plasmid pCD-h'VEGF165. The amplified h'VEGF165 cDNA fragment was identified by enzyme digestion and DNA sequencing methods. Also, wild-type hVEGF165 cDNA was obtained, identified and cloned into a eukaryotic expressing vector pcDNA3 by using the same methods. The results of DNA sequencing showed that h'VEGF165 cDNA cloned from HL601 was 600 bp in size with 8% of the base sequence in h'VEGF165 cDNA being changed as compared with the base sequence in the wild-type hVEGF165 cDNA. The results of sequencing of hVEGF165 which was cloned from HL60 by us were consistent with the reports completely.

通过巢式PCR方法从HL601细胞中扩增出人血管内皮生长因子(h'VEGF165)的新型变体cDNA,并将其克隆到真核表达载体pcDNA3中构建重组质粒pCD-h'VEGF165。扩增的 h'VEGF165 cDNA 片段通过酶消化和 DNA 测序方法进行了鉴定。此外,还用同样的方法获得、鉴定了野生型 hVEGF165 cDNA,并将其克隆到真核表达载体 pcDNA3 中。DNA 测序结果显示,从 HL601 克隆的 h'VEGF165 cDNA 大小为 600 bp,与野生型 hVEGF165 cDNA 的碱基序列相比,h'VEGF165 cDNA 中有 8% 的碱基序列发生了变化。我们从 HL60 克隆的 hVEGF165 的测序结果与相关报道完全一致。
{"title":"Cloning and identification of a novel variant of human vascular endothelial growth factor.","authors":"J Guo, S Qu","doi":"10.1007/BF02886426","DOIUrl":"10.1007/BF02886426","url":null,"abstract":"<p><p>A novel variant of human vascular endothelial growth factor (h'VEGF165) cDNA was amplified by nested PCR method from the HL601 cells and was cloned into a eukaryotic expressing vector pcDNA3 to construct a recombinant plasmid pCD-h'VEGF165. The amplified h'VEGF165 cDNA fragment was identified by enzyme digestion and DNA sequencing methods. Also, wild-type hVEGF165 cDNA was obtained, identified and cloned into a eukaryotic expressing vector pcDNA3 by using the same methods. The results of DNA sequencing showed that h'VEGF165 cDNA cloned from HL601 was 600 bp in size with 8% of the base sequence in h'VEGF165 cDNA being changed as compared with the base sequence in the wild-type hVEGF165 cDNA. The results of sequencing of hVEGF165 which was cloned from HL60 by us were consistent with the reports completely.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 3","pages":"191-4"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22206420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Total cavopulmonary connection for complex cardiac anomalies with the functional single ventricle. 复杂心脏畸形与功能性单心室的全腔肺连接。
Pub Date : 2001-01-01 DOI: 10.1007/BF02888082
X Jinag, Z Sun, K Zhang, P Fu

From Aug. 1999 to Feb. 2001, 8 patients with complex congenital heart diseases, including 5 cases accompanied by hypoplastic left ventricle and 3 by hypoplastic right ventricle, were subjected to total cavopulmonary connection (TCPC). Eight cases underwent the operation under cardiopulmonary bypass and 7 of whom under no cardiac clamp. Seven cases received cavopulmonary anastomosis by flaring method and one case by end-side anastomosis. All the patients underwent the intracardiac tunnels to drain inferior vena cava and plus 4 mm fenestration except one. The results showed that 6 patients had postoperative oxygen saturation more than 90%, sinus rhythm, no anastomostic stoma obstruction, no flow regurgitation and CVP < 16 cmH2O. Two (25%) patients died postoperatively from high venous pressure of 18-20 cmH2O, finally from cardiac failure and anoxima. It was concluded that TCPC was an effective treatment for complex congenital cardiac diseases, especially with ventricular maldevelopment. Intracardiac tunnel plus 4 mm fenestration and flaring cavopulmonary anastomosis could prevent the postoperative complications. Larger anastomotic stoma, venous pressure less than 16 cmH2O and artery saturation more than 90% might indicate excellent TCPC procedures in our experience.

1999年8月至2001年2月,8例复杂先天性心脏病患者接受了全腔肺连接(TCPC)手术,其中5例伴有左心室发育不良,3例伴有右心室发育不良。其中 8 例在心肺旁路下进行手术,7 例在无心脏钳夹下进行手术。七例患者采用扩腔法进行腔肺吻合,一例采用端侧吻合。除一例患者外,所有患者均接受了心内隧道引流下腔静脉和外加 4 毫米瓣膜的手术。结果显示,6 名患者术后血氧饱和度超过 90%,窦性心律,无吻合口阻塞,无血流反流,CVP < 16 cmH2O。两名(25%)患者术后死于 18-20 cmH2O 的高静脉压,最后死于心力衰竭和缺氧。结论是,TCPC 是治疗复杂先天性心脏病,尤其是心室发育不良的有效方法。心内隧道加 4 毫米瓣膜和扩张型腔肺吻合术可预防术后并发症。根据我们的经验,吻合口较大、静脉压小于16 cmH2O、动脉饱和度大于90%可能预示着TCPC手术效果极佳。
{"title":"Total cavopulmonary connection for complex cardiac anomalies with the functional single ventricle.","authors":"X Jinag, Z Sun, K Zhang, P Fu","doi":"10.1007/BF02888082","DOIUrl":"10.1007/BF02888082","url":null,"abstract":"<p><p>From Aug. 1999 to Feb. 2001, 8 patients with complex congenital heart diseases, including 5 cases accompanied by hypoplastic left ventricle and 3 by hypoplastic right ventricle, were subjected to total cavopulmonary connection (TCPC). Eight cases underwent the operation under cardiopulmonary bypass and 7 of whom under no cardiac clamp. Seven cases received cavopulmonary anastomosis by flaring method and one case by end-side anastomosis. All the patients underwent the intracardiac tunnels to drain inferior vena cava and plus 4 mm fenestration except one. The results showed that 6 patients had postoperative oxygen saturation more than 90%, sinus rhythm, no anastomostic stoma obstruction, no flow regurgitation and CVP < 16 cmH2O. Two (25%) patients died postoperatively from high venous pressure of 18-20 cmH2O, finally from cardiac failure and anoxima. It was concluded that TCPC was an effective treatment for complex congenital cardiac diseases, especially with ventricular maldevelopment. Intracardiac tunnel plus 4 mm fenestration and flaring cavopulmonary anastomosis could prevent the postoperative complications. Larger anastomotic stoma, venous pressure less than 16 cmH2O and artery saturation more than 90% might indicate excellent TCPC procedures in our experience.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 2","pages":"149-51"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9663509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Establishment of hepatocellular carcinoma model by allogenic transplantation ]. [通过异基因移植建立肝细胞癌模型 ]。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886435
J Qian, G Feng, J Trübenbach, P E Huppert, P L Pereira, C D Claussen
{"title":"[Establishment of hepatocellular carcinoma model by allogenic transplantation ].","authors":"J Qian, G Feng, J Trübenbach, P E Huppert, P L Pereira, C D Claussen","doi":"10.1007/BF02886435","DOIUrl":"10.1007/BF02886435","url":null,"abstract":"","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 3","pages":"222-4"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9170498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of ligustrazine on hematopoiesis in bone marrow transplantation mice. 利格列嗪对骨髓移植小鼠造血功能的影响
Pub Date : 2001-01-01 DOI: 10.1007/BF02886559
H Sun, M Fang, T Ren, Q Dai, W Liu, W Lu, H Xu

The effect of Ligustrazine on the hematopoiesis after bone marrow transplantation (BMT) in allogenic BMT mice was investigated. After the typical mice model of allogenic BMT had been established, the mice were randomly divided into three groups: BMT group, Ligustrazine group and normal group. The BMT group was given normal saline (0.2 ml, twice a day) through gastric tube, while the Ligustrazine group was given Ligustrazine through gastric tube (0.2 ml, twice a day). At the 1st, 7th and 14th day after BMT, we observed the peripheral blood cells and bone marrow nuclear cells (BMNC), as well as the expression level of Heparan Sulfate (HS) and stromal cell derived factor-1 (SDF-1) on bone marrow sections by using immunohistochemistry (SABC-AP), the expression of CXCR4 on the BMNC. The results showed that on the 7th and 14th day, the peripheral blood white cells, platelets, BMNC and the expression levels of CXCR4, HS and SDF-1 were significantly higher in Ligustrazine group than in the BMT group (P < 0.05). It was concluded that Ligustrazine could promote hematopoiesis at the early stage of hematopoietic reconstitution after BMT.

研究了利格列汀对异基因 BMT 小鼠骨髓移植(BMT)后造血的影响。在建立了典型的异基因 BMT 小鼠模型后,将小鼠随机分为三组:BMT组、藁本嗪组和正常组。BMT 组通过胃管给予正常生理盐水(0.2 毫升,每天两次),而 Ligustrazine 组通过胃管给予 Ligustrazine(0.2 毫升,每天两次)。在 BMT 后的第 1 天、第 7 天和第 14 天,我们观察了外周血细胞和骨髓核细胞(BMNC),并通过免疫组化(SABC-AP)观察了骨髓切片上硫酸肝素(HS)和基质细胞衍生因子-1(SDF-1)的表达水平,以及 BMNC 上 CXCR4 的表达。结果显示,在第 7 天和第 14 天,利格列净组的外周血白细胞、血小板、BMNC 以及 CXCR4、HS 和 SDF-1 的表达水平均显著高于 BMT 组(P < 0.05)。结论是,利格列净可在 BMT 后造血重建的早期阶段促进造血。
{"title":"Effect of ligustrazine on hematopoiesis in bone marrow transplantation mice.","authors":"H Sun, M Fang, T Ren, Q Dai, W Liu, W Lu, H Xu","doi":"10.1007/BF02886559","DOIUrl":"10.1007/BF02886559","url":null,"abstract":"<p><p>The effect of Ligustrazine on the hematopoiesis after bone marrow transplantation (BMT) in allogenic BMT mice was investigated. After the typical mice model of allogenic BMT had been established, the mice were randomly divided into three groups: BMT group, Ligustrazine group and normal group. The BMT group was given normal saline (0.2 ml, twice a day) through gastric tube, while the Ligustrazine group was given Ligustrazine through gastric tube (0.2 ml, twice a day). At the 1st, 7th and 14th day after BMT, we observed the peripheral blood cells and bone marrow nuclear cells (BMNC), as well as the expression level of Heparan Sulfate (HS) and stromal cell derived factor-1 (SDF-1) on bone marrow sections by using immunohistochemistry (SABC-AP), the expression of CXCR4 on the BMNC. The results showed that on the 7th and 14th day, the peripheral blood white cells, platelets, BMNC and the expression levels of CXCR4, HS and SDF-1 were significantly higher in Ligustrazine group than in the BMT group (P < 0.05). It was concluded that Ligustrazine could promote hematopoiesis at the early stage of hematopoietic reconstitution after BMT.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 4","pages":"289-91, 300"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22204941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical significance and assessment of cytokines in various stages of ulcerative colitis. 细胞因子在溃疡性结肠炎各阶段的临床意义及评价。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886564
K Zou, S Liu, X Xie, C Yi

In order to study the clinical significance and change of interleukin (IL)-1 beta and IL-10 concentration in intestinal mucosal tissues in various stage of ulcerative colitis (UC), IL-1 beta and IL10 levels were measured by enzyme linked immunosorbent assays (ELISA). Our results showed that IL-beta level caused by spontaneous secretion in the intestinal mucous tissues in active stage of ulcerative colitis was significantly higher than that in normal controls and in remission stage of ulcerative colitis (P < 0.01, P < 0.001). IL-10 level in various stage of UC was relatively lower in controls, but there was no significantly difference between the two groups. Our study suggested that higher IL-1 beta level in active might play an important role in pathogenesis of UC, and IL-10, as an anti-inflammatory cytokine, was low in active UC, suggesting that it may be a important factor contributing to the development of higher IL-1 beta level.

为了研究溃疡性结肠炎(UC)不同阶段肠黏膜组织中白细胞介素(IL)-1 β和IL-10浓度的变化及其临床意义,采用酶联免疫吸附试验(ELISA)检测IL-1 β和IL-10水平。结果显示,溃疡性结肠炎活动期肠道黏膜组织自发分泌il - β水平显著高于正常对照组和溃疡性结肠炎缓解期(P < 0.01, P < 0.001)。对照组UC各阶段IL-10水平均较低,但两组间差异无统计学意义。我们的研究提示活动期较高的IL-1 β水平可能在UC的发病机制中发挥重要作用,而IL-10作为抗炎细胞因子在活动期UC中较低,这可能是导致IL-1 β水平升高的重要因素。
{"title":"Clinical significance and assessment of cytokines in various stages of ulcerative colitis.","authors":"K Zou,&nbsp;S Liu,&nbsp;X Xie,&nbsp;C Yi","doi":"10.1007/BF02886564","DOIUrl":"https://doi.org/10.1007/BF02886564","url":null,"abstract":"<p><p>In order to study the clinical significance and change of interleukin (IL)-1 beta and IL-10 concentration in intestinal mucosal tissues in various stage of ulcerative colitis (UC), IL-1 beta and IL10 levels were measured by enzyme linked immunosorbent assays (ELISA). Our results showed that IL-beta level caused by spontaneous secretion in the intestinal mucous tissues in active stage of ulcerative colitis was significantly higher than that in normal controls and in remission stage of ulcerative colitis (P < 0.01, P < 0.001). IL-10 level in various stage of UC was relatively lower in controls, but there was no significantly difference between the two groups. Our study suggested that higher IL-1 beta level in active might play an important role in pathogenesis of UC, and IL-10, as an anti-inflammatory cytokine, was low in active UC, suggesting that it may be a important factor contributing to the development of higher IL-1 beta level.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 4","pages":"308-9"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02886564","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22204945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Experimental study of serum substantia nigra neuron autoantibody and its effect in Parkinson disease patients. 帕金森病患者血清黑质神经元自身抗体及其作用的实验研究。
Pub Date : 2001-01-01 DOI: 10.1007/BF02886556
J Chen, X Cao, Y Xu, S Sun

To investigate the serum substantia nigra neuron autoantibody and its effect in the patients with Parkinson disease (PD), substantia nigra slices and a rat model of injection of serum from PD patients in unilateral side substantia nigra were applied. The results showed that the positive rate of substantia nigra neuron autoantibody in PD patients was significantly higher than in the healthy control group (36.67% vs 6.67%, P < 0.01), but no significant difference was found between PD group and myasthenia gravis (MG) group (26.67%, P > 0.05). The sera from PD patients positive for substantia nigra neuron autoantibody could decrease the number of the dopaminergic neurons more seriously than those from MG and the healthy once respectively (both P < 0.01). The results suggested that the immunological mechanism might partly play a role in the development of PD.

为了研究帕金森病(PD)患者血清黑质神经元自身抗体及其作用,采用单侧黑质PD患者血清黑质切片和大鼠注射模型。结果显示,PD患者黑质神经元自身抗体阳性率显著高于健康对照组(36.67% vs 6.67%, P < 0.01), PD组与重症肌无力(MG)组间差异无统计学意义(26.67%,P > 0.05)。PD患者血清中黑质神经元自身抗体阳性,其多巴胺能神经元数量减少的程度明显高于MG组和健康组(P < 0.01)。提示免疫机制可能在PD的发生发展中起一定作用。
{"title":"Experimental study of serum substantia nigra neuron autoantibody and its effect in Parkinson disease patients.","authors":"J Chen,&nbsp;X Cao,&nbsp;Y Xu,&nbsp;S Sun","doi":"10.1007/BF02886556","DOIUrl":"https://doi.org/10.1007/BF02886556","url":null,"abstract":"<p><p>To investigate the serum substantia nigra neuron autoantibody and its effect in the patients with Parkinson disease (PD), substantia nigra slices and a rat model of injection of serum from PD patients in unilateral side substantia nigra were applied. The results showed that the positive rate of substantia nigra neuron autoantibody in PD patients was significantly higher than in the healthy control group (36.67% vs 6.67%, P < 0.01), but no significant difference was found between PD group and myasthenia gravis (MG) group (26.67%, P > 0.05). The sera from PD patients positive for substantia nigra neuron autoantibody could decrease the number of the dopaminergic neurons more seriously than those from MG and the healthy once respectively (both P < 0.01). The results suggested that the immunological mechanism might partly play a role in the development of PD.</p>","PeriodicalId":73995,"journal":{"name":"Journal of Tongji Medical University = Tong ji yi ke da xue xue bao","volume":"21 4","pages":"280-2"},"PeriodicalIF":0.0,"publicationDate":"2001-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02886556","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"22204985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Tongji Medical University = Tong ji yi ke da xue xue bao
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1